Story ProgressBack to home
A doping-free Tour de France? Only time will tell
Maybe they were spooked about getting caught, maybe they've been sly, but the Tour de France was completed without a single rider testing positive.
- Associated Press
- Updated: July 27, 2009 01:15 PM IST
Read Time: 4 min
Paris:
At an event hit by at least one drug scandal every year since 2000, including six in 2008 alone, does the lack of positives mean that the peloton is clean?
Cycling officials, race organizers and many competitors don't dare say so, but many hope the anti-doping fight - with a stiff new testing regime and screening techniques - is bearing fruit.
"I'd say it's being won, I never said it has been won," said Pat McQuaid, head of the International Cycling Union. "Even if we do end up with a positive in this year's Tour, it's not a disaster. The fact is that the culture is changing."
When the race ended on Sunday, with Alberto Contador of Spain taking home his second yellow jersey and seven-time champion Lance Armstrong in an impressive third, the tests for doping did not.
"It's far too early to report on the testing because we haven't received all the test results yet," said Pierre Bordry, head of the French anti-doping agency.
Bordry has expressed concerns that a secret wonder drug could simply be under the radar, in what has become a perennial cat-and-mouse game between cheaters and anti-doping testers.
Anti-doping officials are storing samples after conducting hundreds of tests this year _ meaning that even if testing technology can't turn up positive cases today, maybe some day it will.
Sport officials are bracing for the prospect that positive cases from this Tour could turn up days, weeks or even months from now.
Take Danilo di Luca, who finished second in the Giro d'Italia in May but didn't ride at the Tour. Cycling's governing body suspended him two months after the Giro ended for testing positive for the banned blood-booster CERA.
"Serenity at the Tour de France on this subject doesn't come easy," said race director Christian Prudhomme. "We're not going to imagine that all's the best in all possible worlds.
"There will no doubt be scandals tomorrow. As you saw, there was one in parallel with this Tour - the Di Luca case - though it didn't pollute this Tour."
France's anti-doping agency said on Sunday it will retest blood samples from last year's Tour, mainly for CERA - an advanced form of banned endurance-boosting drug EPO.
They will center on about 15 riders, who were told of the upcoming tests before the start of this year's Tour, said Bordry. He refused to identify the riders. The retesting will take place in September and October.
We didn't want to do it during the Tour because it could have disturbed the competition," Bordry said.
At last year's race, six competitors were caught by doping testers - four for using CERA. They included third-place finisher Bernhard Kohl and three other riders - Italian pair Leonardo Piepoli and Riccardo Ricco and Stefan Schumacher of Germany. Combined, they won five of the 21 stages.
Bordry's agency, known as the AFLD, was in charge of anti-doping tests in last year's Tour. Bordry said the UCI is "the master of the game" this year through a deal with the French agency.
This year's tests didn't always go smoothly. During the second week of racing, Bordry accused the UCI on French radio of "laxity" in the testing. He later said the UCI had resolved his concerns.
The major innovations brought by UCI have been stepped-up testing in and out of competition, and its new and unprecedented "biological passport" program.
"I've said it before: the Tour de France, when you take the number of riders involved, the number of tests they've had, it's probably the most tested event in history," McQuaid said. "So, it wouldn't surprise me if this was a clean Tour."
All 180 competitors this year had blood tests before the race, part of the "biological passport" program, which provides individual profiles of riders' blood parameters.
Before the race, 50 riders faced enhanced testing - including team leaders, race favorites and an unspecified small number of riders with suspicious profiles.
During the race, Lance Armstrong at times grumbled about the many doping tests, though he says he knows they are needed and has welcomed the enhanced checks in the past.
"'Surprise' antidoping control here @ the hotel," he tweeted Friday evening. "11 for this Tour. I'll consider it my appetizer b4 dinner."
Many riders applaud the new anti-doping efforts.
"It's been a breath of fresh air, I'm very happy. We've got to keep in the same direction," said David Millar of Britain, who once served a two-year doping ban and has now become one of the visible anti-doping crusaders in the peloton.
"It's a cultural shift. It's great to see it actually paying dividends."
Maybe they were spooked about getting caught, maybe they've been sly, but the Tour de France was completed on Sunday without a single rider testing positive for doping this year - so far.At an event hit by at least one drug scandal every year since 2000, including six in 2008 alone, does the lack of positives mean that the peloton is clean?
Cycling officials, race organizers and many competitors don't dare say so, but many hope the anti-doping fight - with a stiff new testing regime and screening techniques - is bearing fruit.
"I'd say it's being won, I never said it has been won," said Pat McQuaid, head of the International Cycling Union. "Even if we do end up with a positive in this year's Tour, it's not a disaster. The fact is that the culture is changing."
When the race ended on Sunday, with Alberto Contador of Spain taking home his second yellow jersey and seven-time champion Lance Armstrong in an impressive third, the tests for doping did not.
"It's far too early to report on the testing because we haven't received all the test results yet," said Pierre Bordry, head of the French anti-doping agency.
Bordry has expressed concerns that a secret wonder drug could simply be under the radar, in what has become a perennial cat-and-mouse game between cheaters and anti-doping testers.
Anti-doping officials are storing samples after conducting hundreds of tests this year _ meaning that even if testing technology can't turn up positive cases today, maybe some day it will.
Sport officials are bracing for the prospect that positive cases from this Tour could turn up days, weeks or even months from now.
Take Danilo di Luca, who finished second in the Giro d'Italia in May but didn't ride at the Tour. Cycling's governing body suspended him two months after the Giro ended for testing positive for the banned blood-booster CERA.
"Serenity at the Tour de France on this subject doesn't come easy," said race director Christian Prudhomme. "We're not going to imagine that all's the best in all possible worlds.
"There will no doubt be scandals tomorrow. As you saw, there was one in parallel with this Tour - the Di Luca case - though it didn't pollute this Tour."
France's anti-doping agency said on Sunday it will retest blood samples from last year's Tour, mainly for CERA - an advanced form of banned endurance-boosting drug EPO.
They will center on about 15 riders, who were told of the upcoming tests before the start of this year's Tour, said Bordry. He refused to identify the riders. The retesting will take place in September and October.
We didn't want to do it during the Tour because it could have disturbed the competition," Bordry said.
At last year's race, six competitors were caught by doping testers - four for using CERA. They included third-place finisher Bernhard Kohl and three other riders - Italian pair Leonardo Piepoli and Riccardo Ricco and Stefan Schumacher of Germany. Combined, they won five of the 21 stages.
Bordry's agency, known as the AFLD, was in charge of anti-doping tests in last year's Tour. Bordry said the UCI is "the master of the game" this year through a deal with the French agency.
This year's tests didn't always go smoothly. During the second week of racing, Bordry accused the UCI on French radio of "laxity" in the testing. He later said the UCI had resolved his concerns.
The major innovations brought by UCI have been stepped-up testing in and out of competition, and its new and unprecedented "biological passport" program.
"I've said it before: the Tour de France, when you take the number of riders involved, the number of tests they've had, it's probably the most tested event in history," McQuaid said. "So, it wouldn't surprise me if this was a clean Tour."
All 180 competitors this year had blood tests before the race, part of the "biological passport" program, which provides individual profiles of riders' blood parameters.
Before the race, 50 riders faced enhanced testing - including team leaders, race favorites and an unspecified small number of riders with suspicious profiles.
During the race, Lance Armstrong at times grumbled about the many doping tests, though he says he knows they are needed and has welcomed the enhanced checks in the past.
"'Surprise' antidoping control here @ the hotel," he tweeted Friday evening. "11 for this Tour. I'll consider it my appetizer b4 dinner."
Many riders applaud the new anti-doping efforts.
"It's been a breath of fresh air, I'm very happy. We've got to keep in the same direction," said David Millar of Britain, who once served a two-year doping ban and has now become one of the visible anti-doping crusaders in the peloton.
"It's a cultural shift. It's great to see it actually paying dividends."
Topics mentioned in this article
Cycling
Other Sports
Get the Latest Cricket Updates, Check Bangadesh Tour of India 2024, Schedule, Results and News Updates at NDTV Sports. Like Us On Facebook Or Follow Us On Twitter For More Sports Updates. You Can Also Download The NDTV Cricket App For Android Or iOS.